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Abstract 
Background: Chlamydia trachomatis is responsible for the most common bacterial sexually transmitted 
bacterial infection. The largest burden is in low income countries. These organisms are not screened for in 
Mbarara, and information about the burden of disease is no available. This study aimed at establishing the 
prevalence and factors associated with genital Chlamydia infection among women of reproductive age attending 
the gynecology clinic at Mbarara Regional Referral Hospital. 
Methods:  In a cross-sectional study done at Mbarara Regional Referral Hospital, 324 women aged 15-49years 
were consented and interviewed. Data on socio-demographics, maternal medical conditions, obstetric and 
gynaecological factors and endocervical swabs were collected consecutively from November 2015 to January 
2016 from women attending gynaecology clinic at Mbarara Regional Referral Hospital. Samples were analysed 
using a using CTK biotech Chlamydia kit, which is a rapid immunoassay test for the detection of genital 
chlamydial antigen in urogenital samples. Results were analysed using STATA 13, Logistic regression models 
were used to estimate level of significance, the odds ratios (OR) and 95 % CI of the association between the 
factors and genital infections. Significance was set at a p value of <0.05.  
 Results: Of the 324 samples collected,86 were positive for C. trachomatis antigen giving a prevalence rate of 
26.5%. Of all the associated factors examined, only type of residence was significantly associated with C. 
trachomatis infection (p= 0.0413) with those living in peri-urban areas at greater risk of infection ( aOR 2.4  
95%CI (1.22-4.82). Other social demographic ,medical obstetric and gynecological factors were not associated 
with C. trachomatis infection. No symptom or clinical sign was significant for the infection. 
Conclusion and recommendation: The prevalence of genital C. trachomatis infection among women attending 
gynecology clinic is high. Genital Chlamydia infection has no predictive signs and symptoms in our setting. 
Screening of women in reproductive age should be encouraged. 
Keywords; Genital Chlamydia trachomatis, endocervical swabs, gynaecology clinic.’ 
 
Introduction 
Genital Chlamydia infection is a sexually transmitted infection (STI). It is caused by Chlamydia trachomatis 
which is a gram negative bacterium obligate intracellular parasite  
More than 499 million new cases of curable sexually transmitted infections (gonorrhea, syphilis, Chlamydia 
trachomatis and Trichomona  vaginalis) occur every year globally[1] Chlamydia trachomatis is responsible for 
the most common bacterial sexually transmitted bacterial infection  [2]. In 2005 10million new infections of 
chlamydia in Africa [3]  
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Over ninety percent (90%) of the urogenital infections in women and fifty percent (50%) of the urogenital 
infections in men are asymptomatic[4, 5] . If undetected and not treated, genital Chlamydia infection can ascend 
to the upper genital tract and cause pelvic inflammatory disease (PID) and related sequelae (ectopic pregnancy 
and tubal factor infertility). In women10% - 40% of PID cases are caused by Chlamydia trachomatis. 30-40% of 
PID cases result in infertility and 40-50% of ectopic pregnancies can be attributed to PID [6]. ). There is a 
probability of 16% that an episode of C. trachomatis infection will result in PID, [7]. Untreated genital infections 
(chlamydia and gonorrhoea) account for 85% cases of infertility in sub Saharan Africa, [1].C. trachomatis  
accounts for 22% of infertility in Africa,[8]. During pregnancy untreated Chlamydia infection can increase the 
risk for premature rupture of the membranes, low birth weight, chorioamnionitis, neonatal sepsis and 
conjunctivitis in new borns,[9] 
Many developed countries have developed screening programs to check transmission and long term sequel of 
disease.  Center for Disease Control  in United States recommends annual screening of genital C. trachomatis, 
infection  of all sexually active females aged below twenty six years and older women with risk factors and all 
pregnant women, [10]. In developing countries C. trachomatis is not routinely screened the actual burden of the 
disease is not known Management is based on syndromic approach yet studies have shown a symptoms haw a 
low sensitivity and positive predictive value for detecting chlamydia infections,[11]. This study aims at 
establishing the prevalence of Chlamydia trachomatis infection among women visiting gynecological clinic. It 
will help clinicians and government to decide on whether to embark on community screening of Chlamydia. 
Materials and methods  
Study setting. The study was carried out at gynecology clinic at Mbarara Regional Referral Hospital.  The 
hospital is a teaching hospital located in Western Uganda provides health care services to over ten districts in 
South-western region. The hospital also extends services to other districts that include:  Mubende, Masaka, and 
some parts of the neighbouring countries like the Republic of Rwanda, Burundi, and Democratic Republic of 
Congo and Northern part of Republic of Tanzania. The clinic registers 300 patients per month. 
Study design This was a cross sectional study where 324 eligible women attending the gynaecology  clinic were 
sampled, consented, interviewed, examined and endocervical swabs  were taken off for analysis with the aim of 
identifying evidence of genital tract infections 
Sample collection and analysis. Endocervical swabs were collected from consented participants  using sterile 
plastic-shaft Dacron swabs. Collected samples were analyzed using Chlamydia Rapid Test Device –(CTK 
BioTech,Inc USA). The Chlamydia Rapid Test Device (Swab/Urine) is a qualitative, lateral flow immunoassay 
for the detection of Chlamydia antigen from female cervical swab, male urethral swab. In this test, antibody 
specific to the Chlamydia antigen is coated on the test line region of test. During testing, the extracted antigen 
solution reacts with an antibody to Chlamydia that is coated onto particles. The mixture migrates up to react with 
the antibody to Chlamydia on the membrane and generates a coloured line in the test line region. The presence of 
this coloured line in the test line region indicates a positive result, while its absence indicates a negative result. 
To serve as a procedural control, a coloured line will always appear in the control line region. The test procedure 
was conducted according to the manufacturer’s instruction manual. 
Statistical analysis: The database was imported into STATA 13 soft-ware for analysis. The prevalence of 
genital chlamydia was established as a proportion of patients diagnosed with Chlamydia out of all enrolled 
patients attending gynecology clinic at MRRH. Proportions were used to describe the clinical manifestations of 
patients diagnosed with genital chlamydia.  
A bivariate analysis was done to establish all factors that have a significant relationship with having genital 
chlamydia infections, using logistic regression, at a significance level of 5%. Their crude odds ratios with 95% 
Confidence intervals were generated. 
 All statistically significant and biologically credible factors were subjected to multiple logistic regressions to 
allow adjustment for any confounding. 
 
Results 
Respondents’ characteristics  
The study participants had a mean age of 32 ± 7years. The mean age at 1st sexual intercourse was 18 ± 3 years. 
Most respondents reported one sexual partner in last 1 year. Majority have symptoms suggestive of genital 
infections (64.2%).A large percentage of participants (91.3%) knew about contraceptive methods but only 
45.4%. were using contraceptives. (see table 1) 
Prevalence of genital C.trachomatis 
The proportion of genital chlamydia infection among   women of reproductive age attending gynaecology clinic 
was 26.5 (95% CI 21.7-31.4%).  
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Factors associated with genital C.trachomatis. 
The study showed that only residency type was significantly associated with genital chlamydial infection 
(p=0.0413).  Those staying in peri-  urban areas were more likely to be infected with genital chlamydia infection 
(Crude OR. 2.3, 95% CI-1.17-4.54)(Table 2).The study showed no behavioural characteristics was significantly 
associated with genital chlamydial infection. None of the obstetric factors had a significant association genital 
chlamydia infection. 62.8% and 52.3% of the women with genital chlamydia infection had reported current and 
previous symptoms of genital tract infections respectively. Most women diagnosed with genital chlamydia 
infection (61.6%) were not using contraceptives.(Table 3) 
 
Table 1 showing socio-demographic characteristics of participants 
Characteristics N n (%) 
Mean age in years (sd)  32.2 (7.8) 
Age  in years,  
<25 
25-34 
35-49 
324  
56 (17.3) 
137 (42.3) 
131 (40.4) 
Residency type 
Rural 
Peri-urban 
Urban 
308  
173 (56.2) 
47 (15.3) 
88 (28.6) 
Level of education,  
No formal education  
Primary 
Secondary 
Tertiary 
323  
16 (5) 
167 (51.7) 
92 (28.5) 
48 (14.9) 
Type of occupation,   
Unemployed 
Peasant farmer 
Professional 
Business 
Skilled manual 
318  
44 (13.8) 
114 (35.9) 
41 (12.9) 
83 (26.1) 
36 (11.3) 
Income in Ug. Sh   
<90000 
>=90000 
316  
123 (39.0) 
193 (61.1) 
Marital status  
Single 
Co-habiting 
Married monogamously 
Married polygamously 
Widowed 
Divorced/separated 
322  
22 (6.8) 
66 (20.5) 
164 (51.0) 
31 (9.6) 
16 (5.0) 
23 (7.1) 
Age at 1st intercourse,   
<15 
15-17 
>=18 
321  
12 (3.7) 
113 (35.2) 
196 (61.1) 
Number of sexual partners    
In last 12 months  
0 
1 
>=2 
324  
27 (8.4) 
272 (84.2) 
24 (7.4) 
Previous history of genital infection symptoms,   324 171 (52.8) 
Current history of genital infection symptoms   321 206 (64.2) 
Currently using contraception,  293 133 (45.4) 
Clinical examination  findings   
Genital ulcers 
Vaginitis 
Supra pubic pain 
None  
324  
17 (5.3) 
100 (30.9) 
72 (22.2) 
135 (35.2) 
The participants had a mean age of 32.2years. Most lived in rural areas (56.2% ). 
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Table 2: showing association of socio-demographic characteristics with genital Chlamydia infection. 
Variable No chlamydia 
n(%) 
Chlamydia 
n(%) 
COR [95% CI] p- value 
Age in years  
<25 
25-34 
>35 
 
44 (78.6) 
99 (72.3) 
95 (72.5) 
 
12 (21.4) 
38 (27.7) 
36 (27.5) 
 
1 
 
0.6237 
Residency type 
Rural 
Peri-urban 
urban 
 
131 (75.7) 
27 (57.5) 
67 (76.1) 
 
42 (24.3) 
20 (42.6) 
21 (23.9) 
 
1 
2.3 [1.17-4.54] 
0.9 [0.54-1.78] 
0.0413** 
Tribe.  
Nkore 
Ganda 
Kiga 
other 
 
201 (73.9) 
16 (72.7) 
12 (85.7) 
9 (56.3) 
 
71 (26.1) 
6 (27.3) 
2 (14.3) 
7 (43.6) 
 
1 
1.1 [0.40-2.82] 
0.4 [0.10-2.16] 
2.2 [0.79-6.13] 
0.3272 
Level of education 
 No formal education 
Primary 
Secondary 
Tertiary 
 
15 (93.8) 
 
120 (71.9) 
67 (72.8) 
35 (72.9) 
 
1 (6.3) 
 
47 (28.1) 
25 (27.2) 
13 (27.1) 
 
0.2 [0.02-1.50] 
 
1.1 [0.51-2.17] 
1.0 [0.46-2.20] 
1 
0.1979 
Type of occupation 
Unemployed 
Peasant farmer 
Professional 
Business 
Skilled manual 
 
30 (68.2) 
85 (74.6) 
29 (70.7) 
62 (74.7) 
28 (77.8) 
 
14 (31.8) 
29 (25.4) 
12 (29.3) 
21 (25.3) 
8 (22.2) 
 
1.12 [0.45-2.84] 
0.8 [0.37-1.82] 
1 
0.8 [0.36-1.89] 
0.7 [0.24-1.94] 
0.8697 
Income in Ug. Sh 
<90000 
>=90000 
 
92 (74.8) 
141 (73.1) 
 
31 (25.2) 
52 (26.9) 
 
0.9 [0.5-1.53] 
0.4 [0.27-0.51] 
0.7314 
     
Marital status  
Single 
Co-habiting 
Married monogamously 
Married polygamously 
Widowed 
Divorced/separated 
 
14 (63.6) 
47 (71.2) 
119 (72.6) 
25 (80.7) 
14 (87.5) 
17 (73.9) 
 
8 (36.4) 
19 (28.8) 
45 (27.4) 
6 (19.4) 
2 (12.5) 
6 (26.1) 
 
1.5 [0.59-3.84] 
1.1 [0.57-2.01] 
1 
0.6 [0.24-1.65] 
0.4 [0.08-1.73] 
0.9 [0.35-2.52] 
0.5472 
Duration of relationship 
<2 
2-4 
>=5 
 
18 (90.0) 
41 (77.4) 
135 (70.3) 
 
2 (10.0) 
12 (22.6) 
57 (29.7) 
 
1 
2.6 [0.53-13.0] 
3.8 [0.85-16.92] 
0.0917 
In this study type of residence was significantly associated with genital tract infection. Women staying in peri-
urban areas were two times more likely to have the infection than those staying in rural areas. 
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Table 3: showing association of behavioural, obstetric and gynaecological characteristics with genital Chlamydia 
infection 
Variable No chlamydia 
n(%) 
Chlamydia 
n(%) 
COR [95%CI] p-value 
Drink alcohol  
No 
Yes  
 
203 (72.2) 
35 (81.4) 
 
78 (27.7) 
8 (18.6) 
 
1 
0.5 [0.26-1.34] 
0.1912 
Age at 1st intercourse 
<15 
15-17 
>=18 
 
11 (91.7) 
79 (69.9) 
146 (74.5) 
 
1 (8.3) 
34 (30.1) 
50 (25.5) 
 
0.3 [0.03-2.11] 
1.2 [0.75-2.10] 
1 
0.1853 
Number of sexual partners      
In last 3months  
0 
1 
>=2 
 
36 (75.0) 
193 (72.8) 
9 (81.8) 
 
12 (25.0) 
72 (27.2) 
2 (18.2) 
 
1 
1.1 [0.55-2.27] 
0.6 [0.12-3.52] 
0.7636 
In last 6months  
0 
1 
>=2 
 
24 (75.0) 
200 (72.7) 
14 (82.4) 
 
8 (25.0) 
75 (27.3) 
3 (17.7) 
 
1 
1.1 [0.48-2.61] 
0.6 [0.15-3.83] 
0.6486 
In last 12 months 
0 
1 
>=2 
 
20 (74.1) 
199 (73.2) 
18 (75.0) 
 
7 (25.9) 
73 (26.8) 
6 (25.0) 
 
1 
1.0 [0.43-2.58] 
1.0 [0.15-0.83] 
0.9773 
There were no association between behavioural obstetric and gynaecological characteristics with genital 
Chlamydia infection 
 
 
 
 
 
 
 
Table4: showing adjusted Odds Ratios of factors associated with genital Chlamydia infection 
Parity 
0 
1-2 
3-4 
>=5 
 
 
25 (80.7) 
86 (79.6) 
51 (68.0) 
76 (69.7) 
 
6 (19.4) 
22 (20.4) 
24 (32.0) 
33 (30.3) 
 
1 
1.1 (0.39-2.92) 
2.0 (0.71-5.41) 
1.8 (0.68-4.82) 
0.1748 
Previous history of genital infection 
symptoms   
Currently have symptoms of genital 
infection  
Do you know about contraception   
 
126 (73.7) 
 
152 (64.7) 
 
 217 (73.8) 
45 (26.3) 
 
54 (62.8)  
 
77 (26.2) 
 
1 (0.60-1.60)  
 
 
 
0.7 (0.33-1.73) 
0.9219 
 
0.754 
 
0.5039 
Are you using contraception  
 
102 (75.6) 33 (24.4) 0.8 (0.49-1.36) 0.4340 
HIV serology 
              Negative 
Positive 
 
211 (74.0) 
27 (69.2) 
 
74 (26.0) 
12 (30.8) 
 
1 
1.2 [0.61-2.63] 
0.5295 
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Characteristic adjusted OR [95%CI] p-value 
Age category in years,  
<25 
25-34 
35-40 
 
1 
1.4  [0.68-3.11] 
1.5  [0.71-   3.32] 
 
 
0.332 
0.278 
Residency type 
Rural 
Peri-urban 
urban 
 
1 
2.4 (1.22-4.82) 
0.9 (0.53-1.79) 
 
 
0.011 
0.943 
 Residency type was significantly associated to genital chlamydial infection, with women staying in peri –urban 
areas more likely to be infected.  
 
Table5: Clinical presentations of genital Chlamydia infection 
Characteristics Sample size N No Chlamydia n(%) Chlamydia 
n(%) 
p-value 
History of Abortion 324 59 (24.8) 13 (15.1) 0.064 
History of Ectopic pregnancy  324 8 (3.4 ) 3 (3.5) 0.956 
History of I.U.F.D 324 4 (1.7) 4 (4.7) 0.128 
History of L.B.W 324 1 (0.4) 1 (1.2) 0.451 
History of PROM 324 2 (0.8) 3 (3.5) 0.088 
Current history of genital infection 
symptoms 
321 64.7 62.8 0.754 
Reasons for medical consultation 
Abnormal vaginal discharge 324 61 (25.6) 16 (18.6) 0.190 
Lower abdominal pain 324 126 (52.9) 49 (57.0) 0.520 
Infertility  324 4 (1.7) 4 (4.7) 0.128 
Genital itching   324 17 (7.1) 9 (10.5) 0.331 
Abnormal uterine bleeding 324 22 (9.20 5 (5.8) 0.324 
Dysuria  324 13 (5.5) 8 (9.3) 0.215 
Genital sores  324 3 (1.3) 0 (0.0) 0.296 
Vulvar warts 324 2 (0.8) 1 (1.2) 0.789 
Amenorrhea  324 1 (0.4) 0 (0.0) 0.547 
Screening of CACX 324 4 (1.7) 1 (1.2) 0.738 
Family planning  324 3 (1.3) 1 (1.2) 0.944 
Pelvic mass 324 4 (1.7) 0 (0.0) 0.226 
Medical review  324 9 (3.8) 6 (7.0) 0.227 
Recurrent abortions 324 0 (0.0) 2 (2.3) 0.018 
***0.072 (exact fisher 
test) 
Perineal tear 324 2 (0.8) 0 (0.0) 0.394 
     
Clinical examination  findings  
Genital ulcers 324 15 (6.3 ) 2 (2.3) 0.156 
Vaginitis 324 69 (29.9) 31 (36.1) 0.255 
Supra pubic tenderness 
  
324 52 (72.2) 20 (27.8) 0.788 
 
None of the clinical presentations was predictive of genital chlamydial infection 
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Discussion  
 The prevalence of 26.5% among women attending gynecology clinic is high. Similar results were found in India 
26%   among symptomatic and 21%among  asymptomatic patients [12] and  among Surinamese living in the 
Netherlands visiting high risk STI clinic 20% [13]. 
This prevalence is lower than those found in Jos Nigeria,   South Eastern Nigeria and Zaria Nigeria.56%, 40.7 , 
and 38%.respectively[14-16]. The difference may be explained due to different study settings and Laboratory 
methods. Whereas in this study we used rapid Chlamydia antigen test to detect infection, Okoror et al., used 
culture method which is more sensitive. Tukur et al., performed the study in infertility clinic while this study was 
in general gynaecology clinic. C. trachomatis is known to cause tubal factor infertility these may explain the high 
prevalence. 
 Its higher than the prevalence found in Mozambique 8% [17], North Western Nigeria 9.6%[18], North Western 
Tanzania 12%[11] Kenya 2.8% [19]and 10% among pregnant women at Mbarara regional referral hospital 
(Ouna  et, al. 2010)(unpublished data). These were community studies Whereas this study was hospital based 
study.  
 Factors associated with genital Chlamydia infection 
In this study, only place of residency was significantly associated with genital Chlamydia infection with those 
leaving in peri-urban areas being at increased risk, this concurs with systemic review of studies done in UK 
which showed C. trachomatis is more significant in areas of deprivation,[20]. Residents in peri-urban areas 
demonstrate a more risk sex behavior compared to residents of other areas. [21]. This may explain the increased 
risk of infection among residents of peri-urban areas  
In contrast to this study, previous epidemiological studies on chlamydial infection have identified a variety  of 
risk factors, including the, an age under 25 years , number of partners , contraceptive use, young age at first 
intercourse, previous poor pregnancy outcome[11, 22-25]. The difference may be explained different in 
population characteristics, majority of our participants were above 25years, had one sexual partner in the last 
12months and had 1st sexual intercourse at 18yrs and above. Few participants were using condoms.   
But this study like other studies done in  southern Mozambique , Brazil ,and Ghana no statically significant 
associated of these factors with genital Chlamydia infection was observed [17, 26, 27]  
Clinical presentation of genital Chlamydia infection 
In this study we found no single symptom or clinical sign was significantly associated with genital Chlamydia 
infection.  Similar findings were reported by studies done in Nepal among rural women , Kenya among HIV 
infected women, Botwana among pregnant women. [28-30]           ( Christian et.al  2005,  G Marx, et, al. 2010 
Maria et al. 2007).  
 In a study done in Rakai found only 6% of patients with chlamydia were  symptomatic[5]. In  North Western 
Tanzania, the sensitivity of a syndromic diagnosis PID to detect C. trachomatis, was found to be 17% with 
positive predictive value (PPV) at 12%, [11] 
Conclusion and recommendation  
The prevalence of genital C. trachomatis infection among women attending gynecology clinic at  MRRH is high 
(26.5%). living in peri-urban areas increases the risk of Chlamydia infection.   There are no predictive signs and 
symptoms of genital Chlamydia infection in our setting.. Women of reproductive age should be screened for C. 
trachomatis, to prevent adverse outcomes. 
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